• Risky surgery provides hope for ALS patients

FOX Medical Team’s Beth Galvin reports on Neuralstem’s first NSI-566/ALS Phase II patient, Kathy Lingle, two months post-treatment of ten injections of a total of two million cells at Emory University Hospital in this sweeping feature segment that includes graphic footage of the surgery that “is almost becoming routine.” Site Principal Investigator Dr. Jonathan Glass and Co-Investigator and Neurosurgeon Dr. Nicholas Boulis share insights on exposing “the riskiest real estate in the body,” the cervical spinal cord, “the most important and the most dangerous” in patients’ quest for a cure that Beth Galvin says, “all comes down to one word: hope.”

View Segment